Stevanato Group S.p.A. (NYSE:STVN) Given Average Rating of “Moderate Buy” by Analysts

Stevanato Group S.p.A. (NYSE:STVN) has been assigned a consensus recommendation of “Moderate Buy” from the seven ratings firms that are presently covering the company, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation, two have given a buy recommendation and two have assigned a strong buy recommendation to the company.

Several equities research analysts recently commented on the company. Wolfe Research began coverage on Stevanato Group in a research note on Tuesday, June 2nd. They issued an “outperform” rating and a $21.00 price target for the company. TD Cowen upgraded shares of Stevanato Group to a “strong-buy” rating in a research note on Wednesday, June 17th. UBS Group began coverage on shares of Stevanato Group in a research report on Wednesday. They issued a “neutral” rating and a $23.00 target price for the company. Finally, Weiss Ratings upgraded shares of Stevanato Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, August 27th.

Stevanato Group Price Performance

Shares of NYSE:STVN opened at €20.94 on Friday. The company has a current ratio of 1.61, a quick ratio of 1.08 and a debt-to-equity ratio of 0.21. Stevanato Group has a 1 year low of €12.89 and a 1 year high of €28.00. The business has a fifty day simple moving average of €20.51 and a 200 day simple moving average of €17.82. The firm has a market cap of $6.34 billion, a price-to-earnings ratio of 37.39, a P/E/G ratio of 1.66 and a beta of 0.75.

Stevanato Group (NYSE:STVN) last issued its earnings results on Wednesday, August 5th. The company reported €0.14 EPS for the quarter, missing analysts’ consensus estimates of €0.15 by (€0.01). Stevanato Group had a net margin of 10.99% and a return on equity of 10.43%. The firm had revenue of €302.00 million during the quarter. As a group, sell-side analysts predict that Stevanato Group will post 0.69 earnings per share for the current fiscal year.

Insider Transactions at Stevanato Group

In other Stevanato Group news, Director Elisabetta Magistretti sold 2,045 shares of the business’s stock in a transaction dated Friday, August 7th. The stock was sold at an average price of €20.09, for a total value of €41,084.05. Following the completion of the sale, the director owned 2,930 shares of the company’s stock, valued at €58,863.70. The trade was a 41.11% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Karen Flynn sold 1,493 shares of the company’s stock in a transaction dated Monday, June 15th. The stock was sold at an average price of €17.09, for a total value of €25,515.37. Following the sale, the director owned 5,757 shares of the company’s stock, valued at approximately €98,387.13. This trade represents a 20.59% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 14,249 shares of company stock valued at $268,346 in the last three months. 0.70% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in STVN. Royal Bank of Canada boosted its position in Stevanato Group by 10.8% during the first quarter. Royal Bank of Canada now owns 437,284 shares of the company’s stock worth $8,930,000 after purchasing an additional 42,731 shares during the period. Sei Investments Co. lifted its stake in shares of Stevanato Group by 16.9% in the second quarter. Sei Investments Co. now owns 231,244 shares of the company’s stock worth $5,649,000 after buying an additional 33,419 shares during the last quarter. Raymond James Financial Inc. lifted its stake in shares of Stevanato Group by 21.2% in the second quarter. Raymond James Financial Inc. now owns 567,803 shares of the company’s stock worth $13,871,000 after buying an additional 99,328 shares during the last quarter. Ameriprise Financial Inc. boosted its holdings in shares of Stevanato Group by 14.2% during the 2nd quarter. Ameriprise Financial Inc. now owns 708,821 shares of the company’s stock worth $17,316,000 after buying an additional 87,942 shares during the period. Finally, Bamco Inc. NY boosted its holdings in shares of Stevanato Group by 2.1% during the 2nd quarter. Bamco Inc. NY now owns 1,888,050 shares of the company’s stock worth $46,125,000 after buying an additional 39,528 shares during the period.

Stevanato Group Company Profile

Stevanato Group S.p.A. is an Italy-based developer and manufacturer of drug-containment and drug-delivery solutions for the pharmaceutical, biotechnology and healthcare industries. The company provides products and services designed to support the development, production and administration of injectable medicines.

Its portfolio includes glass vials, cartridges and syringes, as well as other primary packaging components and containment systems. Stevanato Group also offers inspection and packaging equipment, analytical and laboratory services, and drug-delivery technologies such as prefillable syringes and combination-device solutions.